FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 83 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $553,000 | -18.1% | 84,768 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $675,000 | +11.0% | 83,171 | +0.3% | 0.00% | 0.0% |
| Q3 2015 | $608,000 | -27.1% | 82,947 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $834,000 | +8240.0% | 81,346 | +7301.8% | 0.00% | – |
| Q1 2015 | $10,000 | +25.0% | 1,099 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | – | 1,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
| Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
| Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |